 |
PDBsum entry 1lr7
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hormone/growth factor
|
PDB id
|
|
|
|
1lr7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
278:39969-39977
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structures of the heparan sulfate-binding domain of follistatin. Insights into ligand binding.
|
|
C.A.Innis,
M.Hyvönen.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Follistatin associates with transforming growth factor-beta-like growth factors
such as activin or bone morphogenetic proteins to form an inactive complex,
thereby regulating processes as diverse as embryonic development and cell
secretion. Although an interaction between heparan sulfate chains present at the
cell surface and follistatin has been recorded, the impact of this binding
reaction on the follistatin-mediated inhibition of transforming growth
factor-beta-like signaling remains unclear. To gain a structural insight into
this interaction, we have solved the crystal structure of the presumed heparan
sulfate-binding domain of follistatin, both alone and in complex with the small
heparin analogs sucrose octasulfate and D-myo-inositol hexasulfate. In addition,
we have confirmed the binding of the sucrose octasulfate and D-myo-inositol
hexasulfate molecules to this follistatin domain and determined the association
constants and stoichiometries of both interactions in solution using isothermal
titration calorimetry. Overall, our results shed light upon the structure of
this follistatin domain and reveal a novel conformation for a hinge region
connecting epidermal growth factor-like and Kazal-like subdomains compared with
the follistatin-like domain found in the extracellular matrix protein BM-40.
Moreover, the crystallographic analysis of the two protein-ligand complexes
mentioned above leads us to propose a potential location for the heparan
sulfate-binding site on the surface of follistatin and to suggest the
involvement of residues Asn80 and Arg86 in such a follistatin-heparin
interaction.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
FIG. 2. Fs1 structure. Left, ribbon diagram of the Fs1/SOS
structure, highlighting secondary structure elements. Right,
diagrams of the superimposed C[ ]traces for the Fs1
(red), Fs1/SOS (yellow), and Fs1/Ins6S (blue) structures; the
loop involved in crystal contacts is circled, and the SOS and
Ins6S are shown in stick representation. In both halves of this
figure, disulfide bonds are depicted in white with red
numbering, and secondary structure elements are labeled in dark
blue. This figure and the following three-dimensional
representations of molecules were generated using the program
Molscript (50) and rendered with Raster3D (51).
|
 |
Figure 5.
FIG. 5. Interactions between SOS/Ins6S and Fs1. A and B,
binding of SOS (A) and Ins6S (B) to Fs1. Sulfate groups from
these two heparin analogs are numbered, along with protein
residues involved in the interaction. C, superimposition of the
Fs1/SOS (ochre) and Fs1/Ins6S (blue) structures, showing the
relative positioning of sulfate groups in the binding site. D-F,
the interfaces between the heparin-binding region of one Fs1
molecule (blue) and the Kazal-like subdomain of one of its
symmetry-related counterparts (ochre) are depicted for each of
the three Fs1 structures. Residues involved in protein-protein
and additional protein-ligand contacts are labeled, as are the
sulfate groups interacting with the symmetry-related Fs1
molecules.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2003,
278,
39969-39977)
copyright 2003.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.C.Rider,
and
B.Mulloy
(2010).
Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists.
|
| |
Biochem J,
429,
1.
|
 |
|
|
|
|
 |
E.Porten,
B.Seliger,
V.A.Schneider,
S.Wöll,
D.Stangel,
R.Ramseger,
and
S.Kröger
(2010).
The process-inducing activity of transmembrane agrin requires follistatin-like domains.
|
| |
J Biol Chem,
285,
3114-3125.
|
 |
|
|
|
|
 |
S.Sarilla,
S.Y.Habib,
D.V.Kravtsov,
A.Matafonov,
D.Gailani,
and
I.M.Verhamme
(2010).
Sucrose octasulfate selectively accelerates thrombin inactivation by heparin cofactor II.
|
| |
J Biol Chem,
285,
8278-8289.
|
 |
|
|
|
|
 |
A.A.McFarlane,
and
J.Stetefeld
(2009).
An interdomain disulfide bridge links the NtA and first FS domain in agrin.
|
| |
Protein Sci,
18,
2421-2428.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.N.Cash,
C.A.Rejon,
A.C.McPherron,
D.J.Bernard,
and
T.B.Thompson
(2009).
The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding.
|
| |
EMBO J,
28,
2662-2676.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.M.Phelan,
C.T.Thai,
D.C.Soares,
R.T.Ogata,
P.N.Barlow,
and
J.Bramham
(2009).
Solution structure of factor I-like modules from complement C7 reveals a pair of follistatin domains in compact pseudosymmetric arrangement.
|
| |
J Biol Chem,
284,
19637-19649.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Bickel,
R.Shah,
S.C.Gesualdi,
and
T.E.Haerry
(2008).
Drosophila Follistatin exhibits unique structural modifications and interacts with several TGF-beta family members.
|
| |
Mech Dev,
125,
117-129.
|
 |
|
|
|
|
 |
R.E.Saunders,
C.Abarrategui-Garrido,
V.Frémeaux-Bacchi,
E.Goicoechea de Jorge,
T.H.Goodship,
M.López Trascasa,
M.Noris,
I.M.Ponce Castro,
G.Remuzzi,
S.Rodríguez de Córdoba,
P.Sánchez-Corral,
C.Skerka,
P.F.Zipfel,
and
S.J.Perkins
(2007).
The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
|
| |
Hum Mutat,
28,
222-234.
|
 |
|
|
|
|
 |
A.E.Harrington,
S.A.Morris-Triggs,
B.T.Ruotolo,
C.V.Robinson,
S.Ohnuma,
and
M.Hyvönen
(2006).
Structural basis for the inhibition of activin signalling by follistatin.
|
| |
EMBO J,
25,
1035-1045.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.H.Chun,
Y.Yamakoshi,
J.W.Kim,
T.Iwata,
J.C.Hu,
and
J.P.Simmer
(2006).
Porcine SPARC: isolation from dentin, cDNA sequence, and computer model.
|
| |
Eur J Oral Sci,
114,
78.
|
 |
|
|
|
|
 |
Y.Yu,
M.D.Sweeney,
O.M.Saad,
and
J.A.Leary
(2006).
Potential inhibitors of chemokine function: analysis of noncovalent complexes of CC chemokine and small polyanionic molecules by ESI FT-ICR mass spectrometry.
|
| |
J Am Soc Mass Spectrom,
17,
524-535.
|
 |
|
|
|
|
 |
M.J.Cliff,
A.Gutierrez,
and
J.E.Ladbury
(2004).
A survey of the year 2003 literature on applications of isothermal titration calorimetry.
|
| |
J Mol Recognit,
17,
513-523.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |